VIR - Lawmakers agree on $10 billion additional funding for U.S. COVID response (Updated)

Update: Congressional leaders announced an agreement for scaled-back legislation to secure $10 billion in additional funding for U.S. COVID-19 response, New York Daily News reported on Monday. According to a fact sheet distributed by Sen. Mitt Romney (R-Utah), at least half of the measure is earmarked for R&D efforts targeting treatments, and at least $750 million would be allocated for research on new COVID-19 variants and to increase vaccine production. A Democrat of the House Progressive Caucus doubted if the new piece of legislation would garner the minimum 10 GOP votes to advance through the Senate. However, others said that sufficient Republic votes would be there for its passage.  Previously: Congressional negotiators have agreed on a $10 billion additional funding for U.S. COVID-19 response, and the deal is expected to be announced on Monday, The Washington Post reported citing two people with knowledge of the matter.   The package provides funds for the purchase of more

For further details see:

Lawmakers agree on $10 billion additional funding for U.S. COVID response (Updated)